BioCelliX: a case study in biotech spin-out leadership
BioCelliX is a research-stage Senergy venture exploring whether physical features of dividing cells, such as membrane tension, cell shape and how long division takes, could one day help flag cancer risk. It is not a medical device and is not available for clinical use.
- What members do: use a sanitised version of the BioCelliX story as a case study: mapping the funding landscape, drafting a mock grant plan and pitching it to fellows acting as an investment board. They do not work on BioCelliX’s live applications.
- Leadership learned: how spin-outs are governed, how regulatory pathways shape a plan, and how to tell an investor-ready story.